Search
-
Is There Any Room for Pharmacometrics With Immuno-Oncology Drugs? Input from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology
(Anticancer Research. vol. 39, n° 7, pp. 3419-3422, 2019-07-01)Article de revue -
Artificial Intelligence and Mechanistic Modeling for Clinical Decision Making in Oncology
(Clinical Pharmacology and Therapeutics, 2020-06-18)Article de revue -
Mechanistic modeling of metastasis: cancer at the organism scale
Communication dans un congrès -
Machine learning versus mechanistic modeling for prediction of metastatic relapse in breast cancer
Communication dans un congrès -
Practical identifiability analysis of a mechanistic model for the time to distant metastatic relapse and its application to renal cell carcinoma
(PLoS Computational Biology. vol. 18, 2022-08-25)Article de revue -
Asymptotic analysis of a biphase tumor fluid flow: the weak coupling case.
(Applied Mathematics and Computation. vol. 413, pp. 126635, 2022-01-15)Article de revue -
Mechanistic Learning for Combinatorial Strategies With Immuno-oncology Drugs: Can Model-Informed Designs Help Investigators?
(JCO precision oncology. vol. 108, n° 4, pp. 486-491, 2020-09)Article de revue -
Deciphering the response and resistance to immunecheckpoint inhibitors in lung cancer with artificial intelligence-based analysis: the pioneer and quantic joint-projects
(British Journal of Cancer. vol. 123, n° 3, pp. 337-338, 2020-08)Article de revue -
Combinatorial immunotherapy strategies: most gods throw dice, but fate
(Annals of Oncology. vol. 30, n° 11, pp. 1690-1691, 2019-11)Article de revue -
Machine Learning and Mechanistic Modeling for Prediction of Metastatic Relapse in Early-Stage Breast Cancer
(JCO Clinical Cancer Informatics. n° 4, pp. 259-274, 2020-09)Article de revue